Risk Factors of Cetuximab-Induced Hypomagnesemia and the Effect of Magnesium Prophylaxis in Patients with Head and Neck Cancer: A Retrospective Study

In conclusion, a low pre-treatment Mg level was the only risk factor that could be avoided by prophylactic Mg administration. This preventive intervention is recommended for managing cetuximab-induced hypomagnesemia.PMID:38556358 | DOI:10.1248/bpb.b23-00714

Source: Biological and Pharmaceutical Bulletin - March 31, 2024 Category: Drugs & Pharmacology Authors: Ryosuke Matsukane Risa Isshiki Kimitaka Suetsugu Haruna Minami Kojiro Hata Mioko Matsuo Nobuaki Egashira Takeshi Hirota Takashi Nakagawa Ichiro Ieiri Source Type: research